1. Denning DW. Commentary:unusual manifestations of aspergillosis. Thorax, 1995, 50:812-813.
[2]
2. Chrdle A, Mustakim S, Bright-Thomas RJ, et al. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci, 2012, 1272:73-85.
[3]
3. Fernández-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis:report of 8 cases and review of the literature. Medicine (Baltimore), 2012, 91:261-273.
[4]
5. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis, 2000, 30:696-709.
[5]
6. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center:an autopsy study over a 15-year period (1989-2003). Haematologica, 2006, 91:986-989.
8. Patterson TF, Thompson GR, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis:2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63:e1-e60.
[8]
9. Tasci S, Glasmacher A, Lentini S, et al. Pseudomembranous and obstructive Aspergillus tracheobronchitis-optimal diagnostic strategy and outcome. Mycoses, 2006, 49:37-42.
[9]
10. Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation, 2007, 83:1330-1336.
[10]
11. Wu N, Huang Y, Li Q, et al. Isolated invasive Aspergillus tracheobronchitis:a clinical study of 19 cases. Clin Microbiol Infect, 2010, 16:689-695.
[11]
12. Franco J, Munoz C, Vila B, et al. Pseudomembranous invasive tracheobronchial aspergillosis. Thorax, 2004, 59:452.
[12]
4. Li Y, Yu F, Parsons C, et al. Pseudomembranous Aspergillus tracheobronchitis:a potential for high mortality in low-risk patients. Am J Med Sci, 2013, 346:366-370.
